Ola Soderquist - 19 Aug 2024 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Aug 2024, 18:02:35 UTC
Prior SEC filing
17 May 2023
Next SEC filing
28 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Ola Soderquist

Key filing fact

Ola Soderquist filed Form 4 for BIOXYTRAN, INC (BIXT) on 20 Aug 2024.

Key facts

  • This page summarizes Ola Soderquist's Form 4 filing for BIOXYTRAN, INC (BIXT).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Aug 2024, 18:02.

Change

  • Previous filing in this sequence was filed on 17 May 2023.
  • Current net transaction value: +$175,818.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIXT transaction

common

Other

Transaction value
$19,535
Shares
-19,535,300
Change %
-100%
Price
$0.001000
Shares after
0
Date
19 Aug 2024
Ownership
Direct
Footnotes
F1
BIXT transaction

preferred

Other

Transaction value
$195,353
Shares
+3,907,060
Change %
Price
$0.0500
Shares after
3,907,060
Date
19 Aug 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

A 5:1 exchange by insiders shares of Common Stock (earlier issued under Section 16b-3) into shares of Convertible Preferred Stock with a conversion ratio of 1:5 shares into Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .